MedPath

A exploratory study to evaluate the efficacy of the narrow band UVB therapy by Area selection type ultraviolet radiation treatment device in subjects with papuloerythroderma of Ofuji

Not Applicable
Conditions
papuloerythroderma of Ofuji
Registration Number
JPRN-UMIN000031161
Lead Sponsor
Kobe University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

1.Patients with malignant tumor complications 2.Patient with complication of skin malignancy or previous medical history 3.Patients with high cancer risk 4.Patients diagnosed with eczema secondary erythroderma (senile erythroderma), chronic prurigo, atopic dermatitis, drug eruption, lichen planus, eosinophilia syndrome, cutaneous amyloidosis, cutaneous lymphoma , leukemia 5.Patients undergoing Cyclosporine oral administration, etretinate orally,immunosuppressive therapy treatment 6. patients undergoing oral corticosteroid treatment with 21 mg or more per day in terms of prednisolone 7.Patients whose usage, dose of oral treatment, topical treatment has been changed within 2 weeks 8.Patients taking drugs that cause photosensitivity, patients with outstanding photosensitivity 9.Patients who have received UVB ultraviolet radiation therapy within 3 months 10.Patients who participated in other clinical trials within 4 months 11.patients judged inappropriate

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
amaunt of change with Body Surface Area of erythema after irradiation 24 times amaunt of change with erythema and papules after irradiation 24 times
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath